Alyssa Levin

Alyssa Levin serves as the Chief Financial Officer at Radionetics Oncology, where the company focuses on innovative precision radiopharmaceuticals for solid tumor treatment. Prior to this role, Alyssa was the Chief Financial and Business Officer at Nkarta, Inc., working on harnessing natural killer cells for cancer therapy, and the Chief Financial Officer at ViaCyte, contributing to stem cell-derived treatments for diabetes. Alyssa co-founded the Frontline Hero Fund to support healthcare workers affected by COVID-19 and has held various CFO positions at Bird Rock Bio, Tentarix Biotherapeutics, and Cosmederm Bioscience. Previous experience also includes a managerial position at PwC, specializing in capital markets advisory for biotech clients. Alyssa holds multiple degrees in accounting, psychology, and economics from recognized institutions, including the University of Saskatchewan and The University of British Columbia.